Rhea-AI Summary
CounterPath Corporation (NASDAQ:CPAH) announced a prospectus supplement to the SEC for an "at-the-market" equity offering program, allowing the sale of common stock worth up to $5 million. Proceeds will be used for general corporate purposes, including debt repayment and capital expenditures. The offering will be managed by A.G.P./Alliance Global Partners, with commissions at 3.0% of gross proceeds. Sales will not occur in Canada and will adhere to market price conditions. Interested investors should review the prospectus and related documents for detailed information.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.36%
Tags